BE Pharmaceuticals Private Ltd. – FDA 483, Jul 7, 2023
BE Pharmaceuticals Private Ltd. in Tehsil Paonta Sahib, India, was inspected and cited for significant deficiencies across its laboratory, quality, materials, and production systems. Observations include inadequate sterility testing media qualification, deficient method verification, poor OOS investigation practices, unreliable component testing, and failures in aseptic processing area cleaning and personnel hygiene. These issues indicate a lack of robust quality control and assurance for sterile drug product manufacturing.
ID · 9be9667e-7c5c-4308-af25-89856e7b9204
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.